Fairfield, Bush & Co’s Boston Scientific BSX Stock Holding History

Fairfield, Bush & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15	Closed	-$867	–	158
2023 Q4	$867	Buy	+15	New	+$801	﹤0.01%	447
2023 Q3	–	Sell	-15	Closed	-$811	–	154
2023 Q2	$811	Buy	+15	New	+$783	﹤0.01%	476
2022 Q3	–	Sell	-15	Closed	-$1K	–	156
2022 Q2	$1K	Buy	+15	New	+$611	﹤0.01%	412

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fairfield, Bush & Co's BSX Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 15 shares — an estimated $867 sold.

Fairfield, Bush & Co first reported a position in BSX in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Fairfield, Bush & Co reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
Fairfield, Bush & Co sold 15 Boston Scientific shares in Q1 2024, an estimated $867.
Fairfield, Bush & Co first reported a position in Boston Scientific in Q2 2022 and held it in 3 quarters.
Fairfield, Bush & Co's Boston Scientific position peaked at $1K in Q2 2022.
1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.